Metabolic Syndrome in Chemical Warfare Patients with Chronic Obstructive Pulmonary Disease

Authors

  • Abbas Asadi Internist,COPD Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Davood Attaran Pulmonologist,COPD Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Haleh RokniYazdi Endocrinologist,Endocrinology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Hossein Ayatollahi Pathologist, Cancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Majid Ghayour-Mobarhan Clinical Nutrician, Cardiovascular Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Mohammad Khajehdaluee Specialist in Community Medicine,School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Mohammad Towhidi Pulmonologist,COPD Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Omid Shadkam Internist,COPD Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Shahrzad M. Lari Pulmonologist , Cardio-Thoracic Surgery & Transplant Research Center, Emam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract:

  Introduction: Sulfur mustard (SM), a toxic alkylating gas, can cause serious long-term pulmonary complications such as chronic obstructive pulmonary disease (COPD). Metabolic syndrome (MetS) is one of the important comorbidities of COPD. This study was designed to evaluate the frequency of metabolic syndrome in Iranian chemical warfare patients (CWPs) with COPD. Materials and Methods: Thirty CWPs with a mean age of 46.93± 6.8 were enrolled in this study. The following parameters were studied in: complete pulmonary function tests, health-related quality of life, serum triglycerides (TG), high density lipoprotein (HDL) and fasting blood sugar (FBS) levels. Additionally, 32 COPD patients and 56 healthy persons were considered as control groups who were matched to CWPs. Results: We found a statistically significant difference in the frequency of MetS between the COPD patients and the healthy control group (p=0.04). Additionally, we observed a statistically significant difference in the mean HDL levels among these groups (p=

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

metabolic syndrome in chemical warfare patients with chronic obstructive pulmonary disease

introduction: sulfur mustard (sm), a toxic alkylating gas, can cause serious long-term pulmonary complications such as chronic obstructive pulmonary disease (copd). metabolic syndrome (mets) is one of the important comorbidities of copd. this study was designed to evaluate the frequency of metabolic syndrome in iranian chemical warfare patients (cwps) with copd. materials and methods: thirty cw...

full text

Frequency of Metabolic Syndrome in Patients with Chronic Obstructive Pulmonary Disease

Background and purpose: There are controversies on the relationship between metabolic syndrome and chronic obstructive pulmonary disease (COPD). The present study was done to determine the frequency of metabolic syndrome in male patients with COPD as well as the associated illnesses and the symptoms of the disease. Materials and methods: In a cross-sectional survey in Qazvin University of Medi...

full text

Aspergillus colonization in patients with chronic obstructive pulmonary disease

Background and Purpose: Chronic obstructive pulmonary disease (COPD) has been recognized as a risk factor for invasive aspergillosis. Airway colonization by Aspergillus species is a common feature of chronic pulmonary diseases. Nowadays, the incidence of COPD has increased in critically ill patients. The aim of the present study was to isolate and identify Aspergillus colonies in the respirator...

full text

The metabolic syndrome in patients with chronic obstructive pulmonary disease.

PURPOSE This study was undertaken to evaluate the presence of the metabolic syndrome in COPD patients who participated in a cardiopulmonary rehabilitation program. The metabolic syndrome is characterized by the presence of abdominal obesity, atherogenic dyslipidemia, raised blood pressure, presence of insulin resistance, and prothrombotic and inflammatory states that predispose to cardiovascula...

full text

Metabolic syndrome in hospitalized patients with chronic obstructive pulmonary disease

Introduction. The metabolic syndrome (MS) affects 21-53% of patients with chronic obstructive pulmonary disease (COPD) with a higher prevalence in the early stages of COPD, with results being highly variable between studies. MS may also affect natural course of COPD-number of exacerbations, quality of life and lung function. Aim. To examine the prevalence of MS and its correlation with comorbid...

full text

Effect of Pulmonary Rehabilitation Program on Severity of Symptoms in Patients with Chronic Obstructive Pulmonary Disease

800x600 Background and Objectives: Cough and dyspnea are two most common symptoms in chronic obstructive pulmonary disease patients. The aim of this study was to investigate the effect of pulmonary rehabilitation program on severity of symptoms in patients with chronic obstructive pulmonary disease. Materials and Methods: This study was a clinical trial in which 70 patien...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 2  issue 4

pages  231- 237

publication date 2014-11-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023